Pages that link to "Q65592366"
Jump to navigation
Jump to search
The following pages link to stem cell transplantation (Q65592366):
Displayed 50 items.
- hematopoietic stem cell transplantation (Q1128050) (← links)
- Peripheral stem cell transplantation (Q2329938) (← links)
- University Hospital Regensburg (Q2496399) (← links)
- Autologous stem cell transplantation (Q4826373) (← links)
- Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial (Q19862843) (← links)
- Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient (Q21090134) (← links)
- Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? (Q21245473) (← links)
- Biomedical and clinical promises of human pluripotent stem cells for neurological disorders (Q21284798) (← links)
- Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis (Q22306551) (← links)
- Hematopoietic stem cell transplantation for people with sickle cell disease (Q24185759) (← links)
- Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24186359) (← links)
- A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24186913) (← links)
- Stem cell transplantation for systemic sclerosis (Q24187598) (← links)
- Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Q24187751) (← links)
- Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation (Q24187812) (← links)
- Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation (Q24194807) (← links)
- Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults (Q24195048) (← links)
- First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies (Q24197999) (← links)
- Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma (Q24198198) (← links)
- A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Q24198288) (← links)
- Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Q24198774) (← links)
- Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Q24198795) (← links)
- Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Q24198832) (← links)
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma (Q24200183) (← links)
- Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas (Q24200521) (← links)
- Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults (Q24200813) (← links)
- High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma (Q24201885) (← links)
- Hematopoietic stem cell transplantation for Gaucher disease (Q24202044) (← links)
- Hematopoietic stem cell transplantation for people with sickle cell disease (Q24202852) (← links)
- High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults (Q24203878) (← links)
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma (Q24203887) (← links)
- Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas (Q24234049) (← links)
- Interventions for prophylaxis of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation (Q24234757) (← links)
- Stem cell transplantation for ischemic stroke (Q24235315) (← links)
- High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients (Q24235563) (← links)
- Stem cell transplantation for people with ß thalassaemia major (Q24235816) (← links)
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphoma (Q24236260) (← links)
- Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation (Q24240394) (← links)
- Hematopoietic stem cell transplantation for children with sickle cell disease (Q24240994) (← links)
- Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation (Q24241083) (← links)
- Autologous stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas (Q24241435) (← links)
- Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (Q24241475) (← links)
- Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation (Q24241965) (← links)
- High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults (Q24242089) (← links)
- Stem cell transplantation for ischemic stroke (Q24242459) (← links)
- Hematopoietic stem cell transplantation for Gaucher disease (Q24243020) (← links)
- First-line double high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma (Q24243542) (← links)
- Hematopoietic stem cell transplantation for children with sickle cell disease (Q24243548) (← links)
- Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation (Q24245960) (← links)
- High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer (Q24246595) (← links)